Delivery Order SPE2DB24D3015-SPE2DB25FFWRH

Award Date 10/10/24
Potential Completion Date 11/1/24
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,683.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product, with a completion date of September 26, 2024. The contract is a Delivery Order under a Firm Fixed Price (FFP) arrangement. There is no set-aside designation indicated for this award. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical...
This federal contract award, valued at $4,845.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism, and the ultimate completion date is December 31, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a delivery order contract valued at $3,518.40 for the supply of NUBEQA 300 MG TABLET 120S. This order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA...
This federal contract award, with ID SPE2DB22D2007|SPE2DB24FJ5DR, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The $4,683.97 firm fixed price delivery order is for the supply of NUBEQA 300 MG TABLET 120S, a prescription pharmaceutical product. This award is not associated with a set-aside program. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by the DLA and other agencies to...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office Division a Delivery Order contract valued at $3,518.40 for the provision of the pharmaceutical product NUBEQA 300 MG TABLET 120S. This contract has an ultimate completion date of August 5, 2024 and a firm fixed price pricing type. Amerisourcebergen, a major pharmaceutical distribution company, is a prime contractor that holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award, valued at $4,683.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4565519528 - NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of September 11, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the prescription drug NUBEQA 300 MG TABLET 120S to federal government agencies. The contract, valued at $4,683.97, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a completion date of December 10, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $10,555.20, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with the DLA, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,683.97 firm fixed-price delivery order is for the supply of NUBEQA 300 MG tablets, a prescription medication. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,641.98, is for the delivery of 4567624643 ! NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 9, 2025. The contract was awarded on March 19, 2025 and does not have a set-aside...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFWRH
    Delivery Order

This federal contract award, valued at $4,683.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the pharmaceutical product NUBEQA 300 MG TABLET 120S, with a completion date of November 1, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by the DLA and other agencies to supply a wide range of essential medical commodities, including specialty medications, generic drugs, and medical supplies, to support military treatment facilities, veterans' hospitals, and other federal healthcare providers. This specific contract does not have a set-aside designation.

Generated 1/9/25, 9:27 AM